author_facet Gray, Phillip John
Lin, Chun Chieh
Jemal, Ahmedin
Efstathiou, Jason Alexander
Gray, Phillip John
Lin, Chun Chieh
Jemal, Ahmedin
Efstathiou, Jason Alexander
author Gray, Phillip John
Lin, Chun Chieh
Jemal, Ahmedin
Efstathiou, Jason Alexander
spellingShingle Gray, Phillip John
Lin, Chun Chieh
Jemal, Ahmedin
Efstathiou, Jason Alexander
Journal of Clinical Oncology
Temporal trends in the management of localized prostate cancer: From 2004 to 2011.
Cancer Research
Oncology
author_sort gray, phillip john
spelling Gray, Phillip John Lin, Chun Chieh Jemal, Ahmedin Efstathiou, Jason Alexander 0732-183X 1527-7755 American Society of Clinical Oncology (ASCO) Cancer Research Oncology http://dx.doi.org/10.1200/jco.2015.33.7_suppl.42 <jats:p> 42 </jats:p><jats:p> Background: The management of localized prostate cancer (PC) is evolving. We sought to analyze recent management trends using a large national database. Methods: Data on patients presenting with a new diagnosis of PC between 2004 and 2011 were extracted from the National Cancer Data Base. Patients with nodal or distant metastases were excluded. Patients were categorized as low risk (LR), intermediate risk (IR) or high risk (HR) according to the National Comprehensive Cancer Network’s (NCCN) guidelines. Multivariate logistic regression was performed to identify factors associated with the receipt of surgery or radiotherapy. Results: 823,977 patients met the study criteria; 38.5% were LR, 42.7% IR and 18.9% HR. Between 2004 and 2011, for LR patients, rates of observation after diagnosis increased from 12.4% to 18.5% and receipt of radical prostatectomy (RP) increased from 40.3% to 54.4% (p for trend both &lt;.001). In contrast, receipt of brachytherapy decreased from 24.4% to 11.4% and receipt of external beam radiation therapy (EBRT) decreased from 18.2% to 13.4% (p both &lt;.001). For IR patients rates of observation increased from 6.1% to 7.3% and RP from 48.1% to 58.5% (p both &lt;.001) while receipt of brachytherapy decreased from 12.1% to 6.4% (p &lt;.001) and receipt of EBRT plus androgen deprivation therapy (ADT) fell from 14.7% to 8.7%. For HR patients, receipt of RP increased from 30.6% to 41.3% (p &lt; .001) while receipt of EBRT plus ADT decreased from 30.4% to 28.0% (p &lt;.001). On multivariate analysis factors predicting for a lower odds of receiving RP vs. radiotherapy (p all &lt;.001) included black race (OR 0.52 vs. white), lack of insurance or insurance through Medicaid (OR 0.66 and 0.50 vs. private insurance) and residing in low income level areas (OR 0.85 for areas in the lowest national quartile vs. the highest). Conclusions: Utilization of radical prostatectomy for patients with localized PC increased significantly across risk groups from 2004 to 2011 while utilization of radiotherapy decreased. Rates of observation have increased in LR disease but remain low overall. Markers of poor socioeconomic status appear associated with receipt of radiotherapy. Further work is needed to elucidate the causes and appropriateness of these trends. </jats:p> Temporal trends in the management of localized prostate cancer: From 2004 to 2011. Journal of Clinical Oncology
doi_str_mv 10.1200/jco.2015.33.7_suppl.42
facet_avail Online
Free
finc_class_facet Medizin
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTIwMC9qY28uMjAxNS4zMy43X3N1cHBsLjQy
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTIwMC9qY28uMjAxNS4zMy43X3N1cHBsLjQy
institution DE-D275
DE-Bn3
DE-Brt1
DE-Zwi2
DE-D161
DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
DE-105
DE-14
DE-Ch1
DE-L229
imprint American Society of Clinical Oncology (ASCO), 2015
imprint_str_mv American Society of Clinical Oncology (ASCO), 2015
issn 1527-7755
0732-183X
issn_str_mv 1527-7755
0732-183X
language English
mega_collection American Society of Clinical Oncology (ASCO) (CrossRef)
match_str gray2015temporaltrendsinthemanagementoflocalizedprostatecancerfrom2004to2011
publishDateSort 2015
publisher American Society of Clinical Oncology (ASCO)
recordtype ai
record_format ai
series Journal of Clinical Oncology
source_id 49
title Temporal trends in the management of localized prostate cancer: From 2004 to 2011.
title_unstemmed Temporal trends in the management of localized prostate cancer: From 2004 to 2011.
title_full Temporal trends in the management of localized prostate cancer: From 2004 to 2011.
title_fullStr Temporal trends in the management of localized prostate cancer: From 2004 to 2011.
title_full_unstemmed Temporal trends in the management of localized prostate cancer: From 2004 to 2011.
title_short Temporal trends in the management of localized prostate cancer: From 2004 to 2011.
title_sort temporal trends in the management of localized prostate cancer: from 2004 to 2011.
topic Cancer Research
Oncology
url http://dx.doi.org/10.1200/jco.2015.33.7_suppl.42
publishDate 2015
physical 42-42
description <jats:p> 42 </jats:p><jats:p> Background: The management of localized prostate cancer (PC) is evolving. We sought to analyze recent management trends using a large national database. Methods: Data on patients presenting with a new diagnosis of PC between 2004 and 2011 were extracted from the National Cancer Data Base. Patients with nodal or distant metastases were excluded. Patients were categorized as low risk (LR), intermediate risk (IR) or high risk (HR) according to the National Comprehensive Cancer Network’s (NCCN) guidelines. Multivariate logistic regression was performed to identify factors associated with the receipt of surgery or radiotherapy. Results: 823,977 patients met the study criteria; 38.5% were LR, 42.7% IR and 18.9% HR. Between 2004 and 2011, for LR patients, rates of observation after diagnosis increased from 12.4% to 18.5% and receipt of radical prostatectomy (RP) increased from 40.3% to 54.4% (p for trend both &lt;.001). In contrast, receipt of brachytherapy decreased from 24.4% to 11.4% and receipt of external beam radiation therapy (EBRT) decreased from 18.2% to 13.4% (p both &lt;.001). For IR patients rates of observation increased from 6.1% to 7.3% and RP from 48.1% to 58.5% (p both &lt;.001) while receipt of brachytherapy decreased from 12.1% to 6.4% (p &lt;.001) and receipt of EBRT plus androgen deprivation therapy (ADT) fell from 14.7% to 8.7%. For HR patients, receipt of RP increased from 30.6% to 41.3% (p &lt; .001) while receipt of EBRT plus ADT decreased from 30.4% to 28.0% (p &lt;.001). On multivariate analysis factors predicting for a lower odds of receiving RP vs. radiotherapy (p all &lt;.001) included black race (OR 0.52 vs. white), lack of insurance or insurance through Medicaid (OR 0.66 and 0.50 vs. private insurance) and residing in low income level areas (OR 0.85 for areas in the lowest national quartile vs. the highest). Conclusions: Utilization of radical prostatectomy for patients with localized PC increased significantly across risk groups from 2004 to 2011 while utilization of radiotherapy decreased. Rates of observation have increased in LR disease but remain low overall. Markers of poor socioeconomic status appear associated with receipt of radiotherapy. Further work is needed to elucidate the causes and appropriateness of these trends. </jats:p>
container_issue 7_suppl
container_start_page 42
container_title Journal of Clinical Oncology
container_volume 33
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792328171616468992
geogr_code not assigned
last_indexed 2024-03-01T12:49:00.003Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Temporal+trends+in+the+management+of+localized+prostate+cancer%3A+From+2004+to+2011.&rft.date=2015-03-01&genre=article&issn=1527-7755&volume=33&issue=7_suppl&spage=42&epage=42&pages=42-42&jtitle=Journal+of+Clinical+Oncology&atitle=Temporal+trends+in+the+management+of+localized+prostate+cancer%3A+From+2004+to+2011.&aulast=Efstathiou&aufirst=Jason+Alexander&rft_id=info%3Adoi%2F10.1200%2Fjco.2015.33.7_suppl.42&rft.language%5B0%5D=eng
SOLR
_version_ 1792328171616468992
author Gray, Phillip John, Lin, Chun Chieh, Jemal, Ahmedin, Efstathiou, Jason Alexander
author_facet Gray, Phillip John, Lin, Chun Chieh, Jemal, Ahmedin, Efstathiou, Jason Alexander, Gray, Phillip John, Lin, Chun Chieh, Jemal, Ahmedin, Efstathiou, Jason Alexander
author_sort gray, phillip john
container_issue 7_suppl
container_start_page 42
container_title Journal of Clinical Oncology
container_volume 33
description <jats:p> 42 </jats:p><jats:p> Background: The management of localized prostate cancer (PC) is evolving. We sought to analyze recent management trends using a large national database. Methods: Data on patients presenting with a new diagnosis of PC between 2004 and 2011 were extracted from the National Cancer Data Base. Patients with nodal or distant metastases were excluded. Patients were categorized as low risk (LR), intermediate risk (IR) or high risk (HR) according to the National Comprehensive Cancer Network’s (NCCN) guidelines. Multivariate logistic regression was performed to identify factors associated with the receipt of surgery or radiotherapy. Results: 823,977 patients met the study criteria; 38.5% were LR, 42.7% IR and 18.9% HR. Between 2004 and 2011, for LR patients, rates of observation after diagnosis increased from 12.4% to 18.5% and receipt of radical prostatectomy (RP) increased from 40.3% to 54.4% (p for trend both &lt;.001). In contrast, receipt of brachytherapy decreased from 24.4% to 11.4% and receipt of external beam radiation therapy (EBRT) decreased from 18.2% to 13.4% (p both &lt;.001). For IR patients rates of observation increased from 6.1% to 7.3% and RP from 48.1% to 58.5% (p both &lt;.001) while receipt of brachytherapy decreased from 12.1% to 6.4% (p &lt;.001) and receipt of EBRT plus androgen deprivation therapy (ADT) fell from 14.7% to 8.7%. For HR patients, receipt of RP increased from 30.6% to 41.3% (p &lt; .001) while receipt of EBRT plus ADT decreased from 30.4% to 28.0% (p &lt;.001). On multivariate analysis factors predicting for a lower odds of receiving RP vs. radiotherapy (p all &lt;.001) included black race (OR 0.52 vs. white), lack of insurance or insurance through Medicaid (OR 0.66 and 0.50 vs. private insurance) and residing in low income level areas (OR 0.85 for areas in the lowest national quartile vs. the highest). Conclusions: Utilization of radical prostatectomy for patients with localized PC increased significantly across risk groups from 2004 to 2011 while utilization of radiotherapy decreased. Rates of observation have increased in LR disease but remain low overall. Markers of poor socioeconomic status appear associated with receipt of radiotherapy. Further work is needed to elucidate the causes and appropriateness of these trends. </jats:p>
doi_str_mv 10.1200/jco.2015.33.7_suppl.42
facet_avail Online, Free
finc_class_facet Medizin
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTIwMC9qY28uMjAxNS4zMy43X3N1cHBsLjQy
imprint American Society of Clinical Oncology (ASCO), 2015
imprint_str_mv American Society of Clinical Oncology (ASCO), 2015
institution DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229
issn 1527-7755, 0732-183X
issn_str_mv 1527-7755, 0732-183X
language English
last_indexed 2024-03-01T12:49:00.003Z
match_str gray2015temporaltrendsinthemanagementoflocalizedprostatecancerfrom2004to2011
mega_collection American Society of Clinical Oncology (ASCO) (CrossRef)
physical 42-42
publishDate 2015
publishDateSort 2015
publisher American Society of Clinical Oncology (ASCO)
record_format ai
recordtype ai
series Journal of Clinical Oncology
source_id 49
spelling Gray, Phillip John Lin, Chun Chieh Jemal, Ahmedin Efstathiou, Jason Alexander 0732-183X 1527-7755 American Society of Clinical Oncology (ASCO) Cancer Research Oncology http://dx.doi.org/10.1200/jco.2015.33.7_suppl.42 <jats:p> 42 </jats:p><jats:p> Background: The management of localized prostate cancer (PC) is evolving. We sought to analyze recent management trends using a large national database. Methods: Data on patients presenting with a new diagnosis of PC between 2004 and 2011 were extracted from the National Cancer Data Base. Patients with nodal or distant metastases were excluded. Patients were categorized as low risk (LR), intermediate risk (IR) or high risk (HR) according to the National Comprehensive Cancer Network’s (NCCN) guidelines. Multivariate logistic regression was performed to identify factors associated with the receipt of surgery or radiotherapy. Results: 823,977 patients met the study criteria; 38.5% were LR, 42.7% IR and 18.9% HR. Between 2004 and 2011, for LR patients, rates of observation after diagnosis increased from 12.4% to 18.5% and receipt of radical prostatectomy (RP) increased from 40.3% to 54.4% (p for trend both &lt;.001). In contrast, receipt of brachytherapy decreased from 24.4% to 11.4% and receipt of external beam radiation therapy (EBRT) decreased from 18.2% to 13.4% (p both &lt;.001). For IR patients rates of observation increased from 6.1% to 7.3% and RP from 48.1% to 58.5% (p both &lt;.001) while receipt of brachytherapy decreased from 12.1% to 6.4% (p &lt;.001) and receipt of EBRT plus androgen deprivation therapy (ADT) fell from 14.7% to 8.7%. For HR patients, receipt of RP increased from 30.6% to 41.3% (p &lt; .001) while receipt of EBRT plus ADT decreased from 30.4% to 28.0% (p &lt;.001). On multivariate analysis factors predicting for a lower odds of receiving RP vs. radiotherapy (p all &lt;.001) included black race (OR 0.52 vs. white), lack of insurance or insurance through Medicaid (OR 0.66 and 0.50 vs. private insurance) and residing in low income level areas (OR 0.85 for areas in the lowest national quartile vs. the highest). Conclusions: Utilization of radical prostatectomy for patients with localized PC increased significantly across risk groups from 2004 to 2011 while utilization of radiotherapy decreased. Rates of observation have increased in LR disease but remain low overall. Markers of poor socioeconomic status appear associated with receipt of radiotherapy. Further work is needed to elucidate the causes and appropriateness of these trends. </jats:p> Temporal trends in the management of localized prostate cancer: From 2004 to 2011. Journal of Clinical Oncology
spellingShingle Gray, Phillip John, Lin, Chun Chieh, Jemal, Ahmedin, Efstathiou, Jason Alexander, Journal of Clinical Oncology, Temporal trends in the management of localized prostate cancer: From 2004 to 2011., Cancer Research, Oncology
title Temporal trends in the management of localized prostate cancer: From 2004 to 2011.
title_full Temporal trends in the management of localized prostate cancer: From 2004 to 2011.
title_fullStr Temporal trends in the management of localized prostate cancer: From 2004 to 2011.
title_full_unstemmed Temporal trends in the management of localized prostate cancer: From 2004 to 2011.
title_short Temporal trends in the management of localized prostate cancer: From 2004 to 2011.
title_sort temporal trends in the management of localized prostate cancer: from 2004 to 2011.
title_unstemmed Temporal trends in the management of localized prostate cancer: From 2004 to 2011.
topic Cancer Research, Oncology
url http://dx.doi.org/10.1200/jco.2015.33.7_suppl.42